SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-088357
Filing Date
2020-03-27
Accepted
2020-03-27 14:29:03
Documents
2
Group Members
ACCESS INDUSTRIES MANAGEMENT, LLCACCESS INDUSTRIES, LLCCLAL BIOTECHNOLOGY INDUSTRIES LTD.LEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d864461dsc13da.htm SC 13D/A 124035
2 EX-99.5 d864461dex995.htm EX-99.5 9002
  Complete submission text file 0001193125-20-088357.txt   134819
Mailing Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019 212 247 6400
Access Industries Holdings LLC (Filed by) CIK: 0001391297 (see all company filings)

IRS No.: 721620814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Subject) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90553 | Film No.: 20750759
SIC: 2836 Biological Products, (No Diagnostic Substances)